Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis.

Stendig-Lindberg G, Tepper R, Leichter I.

Magnes Res. 1993 Jun;6(2):155-63.

PMID:
8274361
[PubMed - indexed for MEDLINE]
2.
4.

Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.

Tekeoğlu I, Adak B, Budancamanak M, Demirel A, Ediz L.

Rheumatol Int. 2005 Dec;26(2):157-61. Epub 2005 Jan 20.

PMID:
15660234
[PubMed - indexed for MEDLINE]
5.

Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.

Reginster JY, Felsenberg D, Pavo I, Stepan J, Payer J, Resch H, Glüer CC, Mühlenbacher D, Quail D, Schmitt H, Nickelsen T.

Osteoporos Int. 2003 Sep;14(9):741-9. Epub 2003 Jun 19.

PMID:
12827224
[PubMed - indexed for MEDLINE]
6.

Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.

Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K.

Chin Med J (Engl). 2004 Jul;117(7):1029-35.

PMID:
15265377
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.

PMID:
18035193
[PubMed - indexed for MEDLINE]
9.

The effect of alendronate in the treatment of postmenopausal osteoporosis.

Rozkydal Z, Janicek P.

Bratisl Lek Listy. 2003;104(10):309-13.

PMID:
15055730
[PubMed - indexed for MEDLINE]
10.

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.

Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB; Treatment of Osteoporosis with Parathyroid Hormone Study Group.

Ann Intern Med. 2007 Mar 6;146(5):326-39.

PMID:
17339618
[PubMed - indexed for MEDLINE]
11.

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.

Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F.

Lancet. 1997 Aug 23;350(9077):550-5.

PMID:
9284777
[PubMed - indexed for MEDLINE]
12.

Prolonged magnesium deficiency causes osteoporosis in the rat.

Stendig-Lindberg G, Koeller W, Bauer A, Rob PM.

J Am Coll Nutr. 2004 Dec;23(6):704S-11S.

PMID:
15637219
[PubMed - indexed for MEDLINE]
13.

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A.

Ann Intern Med. 2002 Dec 3;137(11):875-83.

PMID:
12458987
[PubMed - indexed for MEDLINE]
14.

Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.

Adami S, Passeri M, Ortolani S, Broggini M, Carratelli L, Caruso I, Gandolini G, Gnessi L, Laurenzi M, Lombardi A, et al.

Bone. 1995 Oct;17(4):383-90.

PMID:
8573412
[PubMed - indexed for MEDLINE]
15.
16.

Clodronic acid in the treatment of postmenopausal osteoporosis.

Tanakol R, Yarman S, Bayraktaroglu T, Boztepe H, Alagöl F.

Clin Drug Investig. 2007;27(6):419-33.

PMID:
17506592
[PubMed - indexed for MEDLINE]
17.

Strontium ranelate: a new paradigm in the treatment of osteoporosis.

Reginster JY, Deroisy R, Jupsin I.

Drugs Today (Barc). 2003 Feb;39(2):89-101. Review.

PMID:
12698204
[PubMed - indexed for MEDLINE]
19.

The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment.

Montessori ML, Scheele WH, Netelenbos JC, Kerkhoff JF, Bakker K.

Osteoporos Int. 1997;7(1):52-8.

PMID:
9102064
[PubMed - indexed for MEDLINE]
20.

A double blind study of intranasal calcitonin for established postmenopausal osteoporosis.

Kapetanos G, Symeonides PP, Dimitriou C, Karakatsanis K, Potoupnis M.

Acta Orthop Scand Suppl. 1997 Oct;275:108-11.

PMID:
9385282
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk